News
- Author:
- Susan London
Publish date: May 22, 2017
Patients with treated early colon cancer who follow a healthy lifestyle and include tree nuts in their diet are less likely to experience recurrenc...
News
- Author:
- Susan London
Publish date: May 19, 2017
Gefitinib is superior to the standard of care chemotherapy for treatment of resected early non–small cell lung cancer harboring an EGFR activating ...
News
- Author:
- Susan London
Publish date: May 18, 2017
Patients who have undergone complete resection of biliary tract cancers live longer if they receive the oral chemotherapy agent capecitabine instea...
News
- Author:
- Susan London
Publish date: May 17, 2017
Though the increase is small, cancer has been detected earlier and more often, indicating future improvements in care.
News
- Author:
- Susan London
Publish date: May 16, 2017
ORLANDO – Three studies focus on risk factors for errors that occur during the delivery of cancer treatment, and how to prevent those errors.
News
- Author:
- Susan London
Publish date: May 2, 2017
How might the first FDA-approved drug for MZL affect ongoing studies and treatment for the disease?
News
- Author:
- Susan London
Publish date: May 2, 2017
The overall response rate was 69% with immune checkpoint inhibitor.
News
- Author:
- Susan London
Publish date: April 19, 2017
The indications for invasive testing and definitive answers about when and how to treat peripheral neuropathies due to Waldenström macroglobulinemi...
News
- Author:
- Susan London
Publish date: March 24, 2017
ORLANDO – Survivorship care models can reduce health care use and costs without compromising outcomes, but quality of care differs across models.
News
- Author:
- Susan London
Publish date: March 21, 2017
ORLANDO – The websites of leading cancer centers often fail to provide critical information about breast cancer treatment.
News
- Author:
- Susan London
Publish date: March 20, 2017
ORLANDO – Tumor-associated mutations go unnoticed surprisingly often.
News
- Author:
- Susan London
Publish date: March 16, 2017
ORLANDO – Reducing variation in patients’ experiences can improve overall quality of care.
News
- Author:
- Susan London
Publish date: March 14, 2017
ORLANDO – How can a new decision support tool reduce CFS use for patients receiving chemotherapy for lung cancer?
News
- Author:
- Susan London
Publish date: March 10, 2017
ORLANDO – Implementation of lung cancer clinical pathways yielded substantial cost savings with no worsening of survival.
News
- Author:
- Susan London
Publish date: February 21, 2017
Ublituximab had good safety and antitumor activity in rituximab-relapsed or -refractory B-cell non-Hodgkin lymphoma or chronic lymphocytic leukemia...
